CREST Site Selection Model Overview - Bioanalysis 2020

Gabe Davila and Clint Mitchell in CDER’s Collaboration, Risk Evaluation & Surveillance Team (CREST) in the Office of Study Integrity and Surveillance (OSIS) describes the types of studies assessed by CREST, evaluates the risk factors used in CREST’s site selection model, examines CREST’s Risk Assessment metrics, and shares challenges CREST faces in its day-to-day work.
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Upcoming training and free continuing education credits: www.fda.gov/cd...
CDER SBIA 2020 Playlist: • 2020 CDER Small Busine...
LinkedIn: / cder-small-business-an...
Training resources: www.fda.gov/cd...
Twitter: / fda_drug_info
CDER small business e-mail update subscription: updates.fda.go...
Email: [e-mail]
Phone: [phone] I [phone]